The EXTRIP (EXtracorporeal TReatments in Poisoning) workgroup: Guideline methodology

Valéry Lavergne, Thomas D. Nolin, Robert S. Hoffman, Darren Roberts, Sophie Gosselin, David S. Goldfarb, Jan T. Kielstein, Robert MacTier, Robert MacLaren, James B. Mowry, Timothy E. Bunchman, David Juurlink, Bruno Megarbane, Kurt Anseeuw, James F. Winchester, Paul I. Dargan, Kathleen D. Liu, Lotte C. Hoegberg, Yi Li, Diane P. CalelloEmmanuel A. Burdmann, Christopher Yates, Martin Laliberté, Brian Scott Decker, Carlos Augusto Mello-Da-Silva, Eric Lavonas, Marc Ghannoum

Research output: Contribution to journalReview article

56 Citations (Scopus)

Abstract

Extracorporeal treatments (ECTRs), such as hemodialysis and hemoperfusion, are used in poisoning despite a lack of controlled human trials demonstrating efficacy. To provide uniform recommendations, the EXTRIP group was formed as an international collaboration among recognized experts from nephrology, clinical toxicology, critical care, or pharmacology and supported by over 30 professional societies. For every poison, the clinical benefit of ECTR is weighed against associated complications, alternative therapies, and costs. Rigorous methodology, using the AGREE instrument, was developed and ratified. Methods rely on evidence appraisal and, in the absence of robust studies, on a thorough and transparent process of consensus statements. Twenty-four poisons were chosen according to their frequency, available evidence, and relevance. A systematic literature search was performed in order to retrieve all original publications regardless of language. Data were extracted on a standardized instrument. Quality of the evidence was assessed by GRADE as: High A, Moderate B, Low C, Very Low D. For every poison, dialyzability was assessed and clinical effect of ECTR summarized. All pertinent documents were submitted to the workgroup with a list of statements for vote (general statement, indications, timing, ECTR choice). A modified Delphi method with two voting rounds was used, between which deliberation was required. Each statement was voted on a Likert scale (19) to establish the strength of recommendation. This approach will permit the production of the first important practice guidelines on this topic.

Original languageEnglish (US)
Pages (from-to)403-413
Number of pages11
JournalClinical Toxicology
Volume50
Issue number5
DOIs
StatePublished - Jun 1 2012

Fingerprint

Poisons
Poisoning
Guidelines
Therapeutics
Hemoperfusion
Nephrology
Politics
Critical Care
Complementary Therapies
Practice Guidelines
Toxicology
Renal Dialysis
Publications
Consensus
Language
Costs
Pharmacology
Costs and Cost Analysis

Keywords

  • Extracorporeal treatments
  • EXTRIP
  • Hemodialysis
  • Hemoperfusion
  • Intoxication
  • Overdose
  • Poisoning

ASJC Scopus subject areas

  • Toxicology

Cite this

Lavergne, V., Nolin, T. D., Hoffman, R. S., Roberts, D., Gosselin, S., Goldfarb, D. S., ... Ghannoum, M. (2012). The EXTRIP (EXtracorporeal TReatments in Poisoning) workgroup: Guideline methodology. Clinical Toxicology, 50(5), 403-413. https://doi.org/10.3109/15563650.2012.683436

The EXTRIP (EXtracorporeal TReatments in Poisoning) workgroup : Guideline methodology. / Lavergne, Valéry; Nolin, Thomas D.; Hoffman, Robert S.; Roberts, Darren; Gosselin, Sophie; Goldfarb, David S.; Kielstein, Jan T.; MacTier, Robert; MacLaren, Robert; Mowry, James B.; Bunchman, Timothy E.; Juurlink, David; Megarbane, Bruno; Anseeuw, Kurt; Winchester, James F.; Dargan, Paul I.; Liu, Kathleen D.; Hoegberg, Lotte C.; Li, Yi; Calello, Diane P.; Burdmann, Emmanuel A.; Yates, Christopher; Laliberté, Martin; Decker, Brian Scott; Mello-Da-Silva, Carlos Augusto; Lavonas, Eric; Ghannoum, Marc.

In: Clinical Toxicology, Vol. 50, No. 5, 01.06.2012, p. 403-413.

Research output: Contribution to journalReview article

Lavergne, V, Nolin, TD, Hoffman, RS, Roberts, D, Gosselin, S, Goldfarb, DS, Kielstein, JT, MacTier, R, MacLaren, R, Mowry, JB, Bunchman, TE, Juurlink, D, Megarbane, B, Anseeuw, K, Winchester, JF, Dargan, PI, Liu, KD, Hoegberg, LC, Li, Y, Calello, DP, Burdmann, EA, Yates, C, Laliberté, M, Decker, BS, Mello-Da-Silva, CA, Lavonas, E & Ghannoum, M 2012, 'The EXTRIP (EXtracorporeal TReatments in Poisoning) workgroup: Guideline methodology', Clinical Toxicology, vol. 50, no. 5, pp. 403-413. https://doi.org/10.3109/15563650.2012.683436
Lavergne V, Nolin TD, Hoffman RS, Roberts D, Gosselin S, Goldfarb DS et al. The EXTRIP (EXtracorporeal TReatments in Poisoning) workgroup: Guideline methodology. Clinical Toxicology. 2012 Jun 1;50(5):403-413. https://doi.org/10.3109/15563650.2012.683436
Lavergne, Valéry ; Nolin, Thomas D. ; Hoffman, Robert S. ; Roberts, Darren ; Gosselin, Sophie ; Goldfarb, David S. ; Kielstein, Jan T. ; MacTier, Robert ; MacLaren, Robert ; Mowry, James B. ; Bunchman, Timothy E. ; Juurlink, David ; Megarbane, Bruno ; Anseeuw, Kurt ; Winchester, James F. ; Dargan, Paul I. ; Liu, Kathleen D. ; Hoegberg, Lotte C. ; Li, Yi ; Calello, Diane P. ; Burdmann, Emmanuel A. ; Yates, Christopher ; Laliberté, Martin ; Decker, Brian Scott ; Mello-Da-Silva, Carlos Augusto ; Lavonas, Eric ; Ghannoum, Marc. / The EXTRIP (EXtracorporeal TReatments in Poisoning) workgroup : Guideline methodology. In: Clinical Toxicology. 2012 ; Vol. 50, No. 5. pp. 403-413.
@article{241400b8a013479e87e9371062777e5d,
title = "The EXTRIP (EXtracorporeal TReatments in Poisoning) workgroup: Guideline methodology",
abstract = "Extracorporeal treatments (ECTRs), such as hemodialysis and hemoperfusion, are used in poisoning despite a lack of controlled human trials demonstrating efficacy. To provide uniform recommendations, the EXTRIP group was formed as an international collaboration among recognized experts from nephrology, clinical toxicology, critical care, or pharmacology and supported by over 30 professional societies. For every poison, the clinical benefit of ECTR is weighed against associated complications, alternative therapies, and costs. Rigorous methodology, using the AGREE instrument, was developed and ratified. Methods rely on evidence appraisal and, in the absence of robust studies, on a thorough and transparent process of consensus statements. Twenty-four poisons were chosen according to their frequency, available evidence, and relevance. A systematic literature search was performed in order to retrieve all original publications regardless of language. Data were extracted on a standardized instrument. Quality of the evidence was assessed by GRADE as: High A, Moderate B, Low C, Very Low D. For every poison, dialyzability was assessed and clinical effect of ECTR summarized. All pertinent documents were submitted to the workgroup with a list of statements for vote (general statement, indications, timing, ECTR choice). A modified Delphi method with two voting rounds was used, between which deliberation was required. Each statement was voted on a Likert scale (19) to establish the strength of recommendation. This approach will permit the production of the first important practice guidelines on this topic.",
keywords = "Extracorporeal treatments, EXTRIP, Hemodialysis, Hemoperfusion, Intoxication, Overdose, Poisoning",
author = "Val{\'e}ry Lavergne and Nolin, {Thomas D.} and Hoffman, {Robert S.} and Darren Roberts and Sophie Gosselin and Goldfarb, {David S.} and Kielstein, {Jan T.} and Robert MacTier and Robert MacLaren and Mowry, {James B.} and Bunchman, {Timothy E.} and David Juurlink and Bruno Megarbane and Kurt Anseeuw and Winchester, {James F.} and Dargan, {Paul I.} and Liu, {Kathleen D.} and Hoegberg, {Lotte C.} and Yi Li and Calello, {Diane P.} and Burdmann, {Emmanuel A.} and Christopher Yates and Martin Lalibert{\'e} and Decker, {Brian Scott} and Mello-Da-Silva, {Carlos Augusto} and Eric Lavonas and Marc Ghannoum",
year = "2012",
month = "6",
day = "1",
doi = "10.3109/15563650.2012.683436",
language = "English (US)",
volume = "50",
pages = "403--413",
journal = "Clinical Toxicology",
issn = "1556-3650",
publisher = "Informa Healthcare",
number = "5",

}

TY - JOUR

T1 - The EXTRIP (EXtracorporeal TReatments in Poisoning) workgroup

T2 - Guideline methodology

AU - Lavergne, Valéry

AU - Nolin, Thomas D.

AU - Hoffman, Robert S.

AU - Roberts, Darren

AU - Gosselin, Sophie

AU - Goldfarb, David S.

AU - Kielstein, Jan T.

AU - MacTier, Robert

AU - MacLaren, Robert

AU - Mowry, James B.

AU - Bunchman, Timothy E.

AU - Juurlink, David

AU - Megarbane, Bruno

AU - Anseeuw, Kurt

AU - Winchester, James F.

AU - Dargan, Paul I.

AU - Liu, Kathleen D.

AU - Hoegberg, Lotte C.

AU - Li, Yi

AU - Calello, Diane P.

AU - Burdmann, Emmanuel A.

AU - Yates, Christopher

AU - Laliberté, Martin

AU - Decker, Brian Scott

AU - Mello-Da-Silva, Carlos Augusto

AU - Lavonas, Eric

AU - Ghannoum, Marc

PY - 2012/6/1

Y1 - 2012/6/1

N2 - Extracorporeal treatments (ECTRs), such as hemodialysis and hemoperfusion, are used in poisoning despite a lack of controlled human trials demonstrating efficacy. To provide uniform recommendations, the EXTRIP group was formed as an international collaboration among recognized experts from nephrology, clinical toxicology, critical care, or pharmacology and supported by over 30 professional societies. For every poison, the clinical benefit of ECTR is weighed against associated complications, alternative therapies, and costs. Rigorous methodology, using the AGREE instrument, was developed and ratified. Methods rely on evidence appraisal and, in the absence of robust studies, on a thorough and transparent process of consensus statements. Twenty-four poisons were chosen according to their frequency, available evidence, and relevance. A systematic literature search was performed in order to retrieve all original publications regardless of language. Data were extracted on a standardized instrument. Quality of the evidence was assessed by GRADE as: High A, Moderate B, Low C, Very Low D. For every poison, dialyzability was assessed and clinical effect of ECTR summarized. All pertinent documents were submitted to the workgroup with a list of statements for vote (general statement, indications, timing, ECTR choice). A modified Delphi method with two voting rounds was used, between which deliberation was required. Each statement was voted on a Likert scale (19) to establish the strength of recommendation. This approach will permit the production of the first important practice guidelines on this topic.

AB - Extracorporeal treatments (ECTRs), such as hemodialysis and hemoperfusion, are used in poisoning despite a lack of controlled human trials demonstrating efficacy. To provide uniform recommendations, the EXTRIP group was formed as an international collaboration among recognized experts from nephrology, clinical toxicology, critical care, or pharmacology and supported by over 30 professional societies. For every poison, the clinical benefit of ECTR is weighed against associated complications, alternative therapies, and costs. Rigorous methodology, using the AGREE instrument, was developed and ratified. Methods rely on evidence appraisal and, in the absence of robust studies, on a thorough and transparent process of consensus statements. Twenty-four poisons were chosen according to their frequency, available evidence, and relevance. A systematic literature search was performed in order to retrieve all original publications regardless of language. Data were extracted on a standardized instrument. Quality of the evidence was assessed by GRADE as: High A, Moderate B, Low C, Very Low D. For every poison, dialyzability was assessed and clinical effect of ECTR summarized. All pertinent documents were submitted to the workgroup with a list of statements for vote (general statement, indications, timing, ECTR choice). A modified Delphi method with two voting rounds was used, between which deliberation was required. Each statement was voted on a Likert scale (19) to establish the strength of recommendation. This approach will permit the production of the first important practice guidelines on this topic.

KW - Extracorporeal treatments

KW - EXTRIP

KW - Hemodialysis

KW - Hemoperfusion

KW - Intoxication

KW - Overdose

KW - Poisoning

UR - http://www.scopus.com/inward/record.url?scp=84861034872&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84861034872&partnerID=8YFLogxK

U2 - 10.3109/15563650.2012.683436

DO - 10.3109/15563650.2012.683436

M3 - Review article

C2 - 22578059

AN - SCOPUS:84861034872

VL - 50

SP - 403

EP - 413

JO - Clinical Toxicology

JF - Clinical Toxicology

SN - 1556-3650

IS - 5

ER -